3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
14
Colorectal Neoplasms
13
Stomach Neoplasms
12
Pancreatic Neoplasms
11
Liver Neoplasms
8
Neuroendocrine Tumors
7
Neoplasm Metastasis
6
Gastrointestinal Neoplasms
4
Esophageal Neoplasms
4
Colonic Neoplasms
4
Neoplasms
3
Digestive System Neoplasms
3
Gastrointestinal Stromal Tumors
2
Gastro-enteropancreatic neuroendocrine tumor
2
Gallbladder Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Breast Neoplasms
2
Adenocarcinoma Of Esophagus
2
Adenocarcinoma
2
Tuberous Sclerosis
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Thrombocytosis
1
Stomach Diseases
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Salivary Gland Neoplasms
1
Interventions
Sorafenib
5
lenvatinib
3
sintilimab
2
pembrolizumab
2
halofantrine
2
camrelizumab
2
atezolizumab
2
Immunotherapy
2
Blood Specimen Collection
2
Bevacizumab
2
Antibodies
2
trifluridine tipiracil drug combination
1
trametinib
1
toripalimab
1
titanium silicide
1
tislelizumab
1
linifanib
1
genexol-PM
1
gadolinium ethoxybenzyl DTPA
1
fluorocholine
1
fisogatinib
1
ficlatuzumab
1
durvalumab
1
bavituximab
1
avelumab
1
User-Centered Design
1
Sunitinib
1
Sufentanil
1
Standard of Care
1
Shadowing Technique, Histology
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Liver Diseases
×
Everolimus
×
Gastrointestinal
×
Clear all
NCT01423708
2012-07-18
EPOCAL
Azienda Ospedaliera di Padova
Phase 2
Unknown
117 enrolled